FDA — authorised 21 January 1987
- Marketing authorisation holder: BRACCO
- Status: approved
FDA authorised Choletec on 21 January 1987
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 21 January 1987; FDA authorised it on 29 January 2008.
BRACCO holds the US marketing authorisation.